Correspondence to Jenny Brouwer, Department of Rheumatology, Erasmus MC, Room no. Na-609, PO Box 2040, Rotterdam 3000 CA, The Netherlands; j.brouwer.1{at}erasmusmc.nl Objectives Many female rheumatoid ...
1 Ministry of Education, Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, China 2 Academy of Mircobial Ecology, Shanxi Medical University, Taiyuan, China 1 Ministry of ...
3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...
Background: Recent EULAR ‘Points to Consider’ provide guidance on management and treatment of Women of Childbearing Age (WoCBA) with chronic rheumatic diseases (CRD: RA, axSpA, PsA). However, it is ...
We read with great interest the recent paper by Aranow et al 1 about the impact of laboratory results on scoring of the Physician Global Assessment (PGA) of disease activity in systemic lupus ...
Objectives The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the ...
Objectives Knee osteoarthritis (KOA) is a leading cause of global disability with conventional exercise yielding only modest improvements. Here we aimed to investigate the benefits of integrating ...
Correspondence to Dr Kiyomi Mizugishi, Department of Hematology, Kyoto University Hospital, Kyoto 606-8507, Japan; kiyomim{at}kuhp.kyoto-u.ac.jp KD is a multisystem vasculitis that primarily affects ...
Correspondence to Professor Andrea Doria, Division of Rheumatology, Department of Medicine, University of Padova, Via Giustiniani, 2, Padova 35128, Italy; adoria{at}unipd.it Aim To identify the ...
Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...
Background Interleukin-23 (IL-23), a key regulator of multiple effector cytokines, has been implicated in the pathogenesis of psoriatic lesions, synovitis, enthesitis, and bone erosion. Risankizumab ...
Objectives Dermatomyositis (DM) has been consistently linked to the type I interferon (IFN-I) pathway. However, the precise pathogenesis remains incompletely elucidated. We aimed to explore potential ...